key: cord-0685289-z7i2jna2
authors: Halfmann, Peter; Nakajima, Noriko; Sato, Yuko; Takahashi, Kenta; Accola, Molly; Chibo, Shiho; Fan, Shufang; Neumann, Gabriele; Rehrauer, William; Suzuki, Tadaki; Kawaoka, Yoshihiro
title: SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
date: 2021-12-07
journal: J Infect Dis
DOI: 10.1093/infdis/jiab587
sha: b4283b0474c9864dd906d65941815b585cddbae9
doc_id: 685289
cord_uid: z7i2jna2

The effects of simultaneous or serial infections with SARS-CoV-2 and influenza virus are unknown. Here, we report that, in a hamster model, SARS-CoV-2 infection at the same time as or prior to H3N2 influenza virus infection resulted in significantly reduced influenza virus titers in the lungs and nasal turbinates of infected animals. This interference of influenza virus replication may correlate with SARS-CoV-2-induced expression of the antiviral gene MX1.

A c c e p t e d M a n u s c r i p t 3

Simultaneous infections or coinfections with more than one respiratory virus is not uncommon in humans, particularly in hospital settings [1] . The epidemiology of disease caused by a single virus infection can be altered or influenced by a second virus infection [2] .

Given the vast array of known respiratory viruses such as influenza viruses, coronaviruses, rhinoviruses, and parainfluenza viruses, the disease outcomes for the various mixed respiratory viral infections are unclear. Some coinfections can enhance disease severity; for example, coinfection of reovirus and severe acute respiratory syndrome (SARS) coronavirus in guinea pigs leads to a more severe disease phenotype [3] .

Commonly in coinfections, one virus will interfere with and suppress the replication of the other virus. This suppression can be due to competition for host factors or sites of virus replication and may be influenced by host immune responses such as those activated by interferons and interferon-stimulated genes (ISGs) [4] . One of the best studied family of ISGs with antiviral activity against multiple RNA viruses, including influenza viruses, are the myxovirus resistance (Mx) proteins [5] . Because SARS-CoV-2 induces strong, diffuse Mx1 expression in the lungs of infected hamsters [6] , we decided to examine the interference of influenza virus replication in Syrian golden hamsters coinfected or previously infected with SARS-CoV-2.

Vero E6 TMPRSS2 cells were maintained in DMEM with 10% fetal bovine serum in the presence of 1 mg ml -1 of geneticin. Humanized MDCK (hCK) cells were maintained in MEM containing 5% newborn calf serum in the presence of 2 µg ml -1 of puromycin and 10 µg ml -1 blasticidin. All cells were incubated at 37 o C with 5% CO 2 and were confirmed to be mycoplasma negative by PCR testing. All experiments were performed in enhanced BSL-3 containment laboratories at the University of Wisconsin, which are approved for such use by the CDC and USDA.

The number of animals used in each experiment was chosen based on our previous studies with SARS-CoV-2 and influenza virus infection of hamsters, in which the sample size was sufficient to evaluate a statistically significant difference between groups. All studies were conducted under an approved protocol reviewed by the Institutional Animal Care and Use Committee at the University of Wisconsin.

In this study, 4-5-week-old female Syrian golden hamsters (Envigo) were used.

Under isoflurane anesthesia, four hamsters per group were inoculated with SARS-CoV-2 

For virological and pathological analyses, animals were euthanized, and samples (lungs and nasal turbinates) were collected on the days indicated in Titers performed in duplicate were determined by performing plaque assays in Vero E6

A c c e p t e d M a n u s c r i p t 5 The remaining lung tissues were fixed in 10% neutral buffered formalin and then embedded in paraffin. Tissue sections (3 µm) were cut and mounted onto glass slides for either standard hematoxylin and eosin staining or immunohistochemical staining for viral antigens. A rabbit polyclonal antibody for the SARS nucleocapsid (N) (ANT-180, Prospec, NJ, USA), a rabbit polyclonal antibody for type A influenza virus nucleoprotein (NP) (prepared in our laboratory), or a mouse monoclonal antibody for MX1 (clone M143, Merck Millipore, CA, USA) were used for antigen staining; reactions were visualized by using 3,3'diaminobenzidine tetrahydrochloride and the Dako Envision system.

Visual observations of lung lobe inflammation were scored from 0-4 depending on severity. Each lung lobe was analyzed for degree of inflammation and scored as 0 (none, 0%), 1 (minimal, <10%), 2 (mild, 10%-50%), 3 (moderate, >50%), or 4 (severe, score 3+ edema or/and hemorrhage) by a scorer not blinded to the group allocation.

Virus titers from animals are expressed as scatter plots with bars and individual data points obtained by using Graphpad Prism 9. Statistical analyses between two groups were performed using unpaired Student's t-tests. The data that support these findings of this study are available from the corresponding authors upon reasonable request.

Syrian hamsters are a useful animal model for studying both influenza A virus [7] and SARS- concentrations and volume (Fig. 1a) . Three days after infection, there was no statistically significant difference in the ability of SARS-CoV-2 to replicate in both the lungs (p-value = 0.3678) and nasal turbinates (p-value = 0.7048) in the coinfected animals compared with the animals infected with only SARS-CoV-2 (Fig. 1a) . However, influenza virus replication was impaired in the group of coinfected animals; influenza virus titers were reduced in the lungs (p-value = 0.0326) and undetectable in the nasal turbinates (p-value <0.0001) relative to that in the group of hamsters infected with only influenza virus (Fig. 1a) .

Given the inhibition of influenza virus replication in the simultaneous infection study, we next performed serial infection studies focusing on the potential inhibition of influenza virus by SARS-CoV-2. Groups of hamsters (four hamsters per group) were first infected with SARS-CoV-2 or were inoculated with PBS (Fig. 1b) . Ten days later, a time period after infection associated with no-to-limited SARS-CoV-2 replication in the lungs of different animals but at which strong innate immune and inflammatory responses are still present [6, 8, 9] , the animals were infected with influenza virus. Influenza virus replication in the lungs and nasal turbinates was significantly impaired (p-values = 0.0245 and 0.0099, respectively) in hamsters previously infected with SARS-CoV-2 compared with control hamsters inoculated with PBS and then infected with influenza virus (Fig. 1b) . Interestingly, 21 days after the first infection with SARS-CoV-2 (a time period after infection at which we anticipated that the host responses to infection would have cleared), hamsters infected with influenza virus also showed impairment of virus replication in the nasal turbinates (p-value = 0.0022), but no significant reduction of virus replication in the lungs (p-value = 0.1047), although two of the four animals in this group had no detectable virus replication in the lungs (Fig. 1c) .

In contrast, when animals were first infected with influenza virus, and then infected with SARS-CoV-2 10 days later (to be consistent with the length of time between infections in the above-described experiment), the previous infection with influenza virus had no effect To gain further insight into the mechanism of SARS-CoV-2 interference of influenza virus infection, we examined lung pathology. Hematoxylin and eosin staining revealed notable inflammation in the lungs of hamsters that were infected with SARS-CoV-2 first even 10 days after infection relative to control animals inoculated with PBS ( Supplementary Fig. 1 and Supplementary Table 1) , which is consistent with previously published data [9] , while immunohistochemically staining of the lung tissues revealed no SARS-CoV-2 nucleocapsid Table 1 and Supplementary Fig. 1 (PBS + H3N2) ]. The inflammation in the lungs after influenza infection was not exacerbated by the previous SARS-CoV-2 infection (Supplementary Table   1 ). but influenza NP antigen was less abundant (Supplementary Fig. 1 [CoV-2 + H3N2]) which is consistent with a reduction in influenza virus titers.

With animals previously infected with SARS-CoV-2 10 days prior, influenza virus NP antigen was less abundant (Supplementary Fig. 1 [CoV-2 + H3N2]) and found only in 50% of the animals (Supplementary Table 1 ); the animals that were viral antigen-positive by immunohistochemistry were also live virus-positive (Fig. 1b) .

It has been reported that SARS-CoV-2-infected hamsters express detectable levels of the antiviral gene MX1 in their lungs [6] . Because replication of influenza viruses is restricted by this cellular ISG [10] , we examined the expression of MX1 10 days after the SARS-CoV-2 infection and after the sequential infection with influenza virus. While there was no detectable staining of MX1 in the lungs of control hamsters inoculated with PBS (Fig. 2a) , MX1 was still detectable even 10 days after the SARS-CoV-2 infection (Fig.2b) , similar to A c c e p t e d M a n u s c r i p t 8 previously reported findings [6] . Infection of PBS control hamsters with influenza virus induced the strongest expression of MX1 at Day 3 after infection (Fig. 2c) . However, this increase in MX1 expression three days after influenza virus infection was not apparent in hamsters previously infected (10 days prior) with SARS-CoV-2 (compare Fig. 2c and 2d ).

This result most likely reflects the suppression of influenza virus replication by several host factors including MX1 that were induced by the previous SARS-CoV-2 infection. Further research is needed to fully understand the contribution of MX1 to this phenomenon.

In humans, coinfections of influenza virus and SARS-CoV-2 have been documented [11, 12] .

Here, we demonstrated that Syrian golden hamsters are an ideal animal model to examine the consequences of simultaneous and serial infection of SARS-CoV-2 and influenza virus, as well as the host factors (e.g., antiviral genes like MX1) that are induced by one virus to suppress the other virus. Here, our group and others [6] have shown that MX1 is induced by SARS-CoV-2 infection, although other ISGs may also play a role in the inhibition of influenza virus infection during co-and serial infections with SARS-CoV-2. These other host factors should be explored in more detail both in cell culture systems, such as human air organoids, and animal models including knock-out mice. The long-term persistence of SARS-CoV-2 RNA in tissues after infection has been noted in human lung tissue [13] , and may trigger the activation of the interferon pathway leading to persistent induction of ISGs including MX1.

Although our data suggest the induction of MX1 by SARS-CoV-2 restricts influenza virus infection, the induction of MX1 by influenza virus had no effect on SARS-CoV-2 replication, an observation of potential antagonism of MX1 function by SARS-CoV-2 that should be further studied. A c c e p t e d M a n u s c r i p t 9 influenza virus and SARS-CoV-2 [14] . This difference in results might be due to better replication of H1N1 influenza viruses in hamsters relative to H3N2 influenza viruses or a stronger resistance of pandemic 2009 H1N1 influenza viruses to the antiviral gene MX1 [15] .

The outcome of coinfection could also be dependent on the SARS-CoV-2 variant used to infect hamsters, a variable not explored in this manuscript, but worth investigating in future studies given the diverse panel of SARS-CoV-2 variants that has emerged. 

Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality

Mixed viral infections: detection and management

Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients

Virological and Immunological Outcomes of Coinfections

Mx proteins: antiviral gatekeepers that restrain the uninvited

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Immune Response, Inflammation, and the Clinical Spectrum of COVID-19

Mx-Genes, and Resistance to Influenza-Virus

Co-infection with SARS-CoV-2 and influenza A virus

Coinfection with SARS-CoV-2 and Influenza A Virus in a 32-Year-Old Man

Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19

Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters

Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly

We thank Susan Watson for scientific editing. This work was supported in part by a grant 

A c c e p t e d M a n u s c r i p t